Skip to main content

Advertisement

Log in

Assessment of perfusion, function, and myocardial metabolism after infarction with a combination of low-dose dobutamine tetrofosmin gated SPECT perfusion scintigraphy and BMIPP SPECT imaging

  • Original Articles
  • Published:
Journal of Nuclear Cardiology Aims and scope

Abstract

Background

Tetrofosmin gated single photon emission computed tomography (SPECT) allows simultaneous assessment of regional myocardial perfusion, global and regional left ventricular function, and function at rest and during pharmacologic intervention. SPECT with fatty acid analogues, such as β-methyl-iodophenyl-pentadecanoic acid (BMIPP), can be used to monitor metabolic changes induced by myocardial ischemia. In this work, the results of both studies obtained in patients with recent myocardial infarction are integrated.

Methods

Twenty patients underwent tetrofosmin and BMIPP scintigraphy with a 3-head camera. Two consecutive tetrofosmin gated SPECT acquisitions were performed 60 minutes after administration of technetium-99m tetrofosmin (925 MBq) at rest (3×20 stops of 9 s; matrix 64×64 over 360°. One acquisition was made at rest, and the second was made during dobutamine infusion (10 μg/kg/min). Regional functional abnormalities were quantified and expressed as wall thickening severity (WTsev) in arbitrary units. Left ventricular ejection fraction and volumes were assessed with the Cedars Sinai algorithm. BMIPP imaging started 20 minutes after iodine 123-BMIPP (150 MBq) administration at rest (3×32 stops of 60 s; matrix 64×64 over 360°; medium energy collimators). Tracer uptake was scored according to a 25-segment model.

Results

Sixteen of 18 patients had regional functional abnormalities at baseline (average WTsev 13.7 units). The WTsev score at baseline correlated well with the degree of residual perfusion. During dobutamine infusion, WTsev did not change (from 23.4 to 23.6 units) in 5 patients; it decreased (from 16.1 to 5.9 units) in 11 patients; and it increased (from 13.0 to 22.3 units) in 3 patients. An increase or decrease in WTsev during dobutamine infusion was associated with the presence of a considerable amount of BMIPP mismatched myocardium, whereas no change in WTsev was preferentially associated with a BMIPP matched pattern and perfusion defects with a higher severity score.

Conclusion

Immediately after infarction, the severity of regional dysfunction at rest correlated well with the perfusion defect severity. Improvement in regional function during dobutamine administration is associated with less severe perfusion defects and a considerable amount of BMIPP mismatched myocardium, both suggesting viability.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bonow R. Identification of viable myocardium. Circulation 1996;94:2674–80.

    PubMed  CAS  Google Scholar 

  2. Opie LH, Hesse B. Radionuclide tracers in the evaluation of resting myocardial ischaemia and viability. Eur J Nucl Med 1997;24:1183–93.

    PubMed  CAS  Google Scholar 

  3. Pierard LA, Landsheere CM, Berthe C, et al. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy, comparison with positron emission tomography. J Am Coll Cardiol 1990;15:1021–31.

    PubMed  CAS  Google Scholar 

  4. Smart SC, Sawada S, Ryan Th, et al. Low dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993;88:405–15.

    PubMed  CAS  Google Scholar 

  5. Hawman PC, Haines EJ. The Cardiofocal collimator: a variable-focus collimator for cardiac SPET. Phys Med Biol 1994;39:439–50.

    Article  PubMed  CAS  Google Scholar 

  6. Everaert H, Vanhove C, Hamill JJ, et al. Cardiofocal collimators for gated single-photon emission tomographic myocardial perfusion imaging. Eur J Nucl Med 1998;25:3–7.

    Article  PubMed  CAS  Google Scholar 

  7. Franken PR, DeGeeter F, Dendale P, et al. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med 1994;35:1758–65.

    PubMed  CAS  Google Scholar 

  8. Franken PR, Dendale P, DeGeeter F, et al. Prediction of functional outcome after myocardial infarction using BMIPP and sestamibi scintigraphy. J Nucl Med 1996;37:718–22.

    PubMed  CAS  Google Scholar 

  9. Everaert H, Vanhove C, Schoors D, et al. Quantitative assessment of regional dysfunction from gated single-photon emission tomography myocardial perfusion studies: a non-segmental approach. Nucl Med Commun 1999;20:335–43.

    Article  PubMed  CAS  Google Scholar 

  10. Germano G, Kiat H, Kavanagh P, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995;36:2138–47.

    PubMed  CAS  Google Scholar 

  11. Mertens J, Eersels J, Vanryckeghem W. New high yield Cu(1) assisted 123I radioiodination of 15 (p-1-phenyl)-9-methyl pentadecanoic acid, a potential myocardial tracer. Eur J Nucl Med 1987;13:159–60.

    Article  PubMed  CAS  Google Scholar 

  12. DeGeeter F, Franken PR, Defrise M, et al. Optimal colimator choice for sequential iodine-123 and technetium-99m imaging. Eur J Nucl Med 1996;23:768–74.

    Article  Google Scholar 

  13. Chua T, Kiat H, Germano G, et al. Gated technetium-99m sestamibi for simultaneous assessment of myocardial perfusion postexercise regional ventricular function and myocardial viability. Correlation with echocardiography and rest thallium-201 scintigraphy. J Am Coll Cardiol 1994;23:1107–14.

    PubMed  CAS  Google Scholar 

  14. Tischler MD, Niggel JB, Battle RW, Fairnbank JT, Brown KA. Validation of global and segmental left ventricular contractile function using gated planar technetium-99m sestamibi myocardial perfusion imaging. J Am Coll Cardiol 1994;23:141–5.

    Article  PubMed  CAS  Google Scholar 

  15. Anagnostopoulos C, Gunning MG, Pennel DJ, Laney R, Proukakis H, Underwood SR. Regional myocardial motion and thickening assessed at rest by ECG-gated 99mTc-MIBI emission tomography and by magnetic resonance imaging. Eur J Nucl Med 1996;23:909–16.

    Article  PubMed  CAS  Google Scholar 

  16. Stollfuss JC, Haas F, Matsunari I, et al. Regional myocardial wall thickening and global ejection fraction in patients with low angiographic left ventricular ejection fraction assessed by visual and quantitative resting ECG-gated 99mTc-tetrofosmin single-photon emission tomography and magnetic resonance imaging. Eur J Nucl Med 1998;25:522–30.

    Article  PubMed  CAS  Google Scholar 

  17. Gunning MG, Anagnostopoulos C, Davies G, Forbat SA, Ell PJ, Underwood R. Gated technetium-99m-tetrofosmin SPECT and cine MRI to assess the ventricular contraction. J Nucl Med 1997;38:39–442.

    Google Scholar 

  18. Everaert H, Vanhove C, Franken RR. Effects of low-dose dobutamine on left ventricular function in normal subjects as assessed by gated single-photon emission tomography myocardial perfusion studies. Submitted to Eur J Nucl Med.

  19. Tamaki N, Kawamoto M, Yonekura Y, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infraction: assessment with emission tomography using an iodinated branched fatty acid analogue. J Nucl Med 1992;33:659–67.

    PubMed  CAS  Google Scholar 

  20. DeGeeter F, Franken PR, Knapp RR Jr, et al. Relationship between blood flow and fatty acid metabolism in subacute myocardial infarction: a study by means of 99mTc-MIBI and 123I-beta-methyl iodophenyl pentadecanoic acid. Eur J Nucl Med 1994;21:283–91.

    Article  CAS  Google Scholar 

  21. Arnese M, Cornel JH, Salustri A, et al. Prediction of improvement in regional left ventricular function after surgical revascularization. A comparison of low dose dobutamine echocardiography with 201Tl single-photon emission computed tomography. Circulation 1995; 91:2748–52.

    PubMed  CAS  Google Scholar 

  22. Panza JA, Dilsizian V, Laurienzo JM, Curici RV, Katsiyiannis PT. Relation between thallium uptake and contractile response to dobutamine. Implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation 1995;91:990–8.

    PubMed  CAS  Google Scholar 

  23. Melon PG, de Landsheere CM, Degueldre C, Peters JL, Kulbertus HE, Pierard LA. Relation between contractile reserve and positron emission tomographic patterns of perfusion and glucose utilization in chronic ischemic left ventricular dysfunction: implications for identification of myocardial viability. J Am Coll Cardiol 1997;30:1651–9.

    Article  PubMed  CAS  Google Scholar 

  24. Kitsiou AN, Srinivasan G, Quyyumi AA, Summers RM, Bacharach SL, Dilsizian V. Stress-induced reversible and mild-to-moderate irreversible thallium defects: are they equally accurate for predicting functional recovery of regional left ventricular function after revascularization? Circulation 1998;98:501–8.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hendrik Everaert.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Everaert, H., Vanhove, C. & Franken, P.R. Assessment of perfusion, function, and myocardial metabolism after infarction with a combination of low-dose dobutamine tetrofosmin gated SPECT perfusion scintigraphy and BMIPP SPECT imaging. J Nucl Cardiol 7, 29–36 (2000). https://doi.org/10.1067/mnc.2000.103135

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1067/mnc.2000.103135

Key Words

Navigation